Author

Brett L. Knolhoff

Washington University in St. LouisORCID 0000-0002-0115-7355Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

David G. DeNardoiD· 1 shared Kian‐Huat LimiD· 1 shared Lin LiiD· 1 shared Marianna B. RuzinovaiD· 1 shared Ryan Courtney FieldsiD· 1 shared Sapana BansodiD· 1 shared Suneeta Modekurty· 1 shared Timothy Hung-Po CheniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

David G. DeNardoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting Tumor-intrinsic TAK1 triggers anti-tumor immunity and sensitizes pancreatic cancer to checkpoint blockade

Sapana Bansod, Timothy Hung-Po Chen, Vikas Somani, Lin Li, Suneeta Modekurty, Brett L. Knolhoff, Ryan Courtney Fields, Marianna B. Ruzinova, David G. DeNardo, Kian‐Huat Lim

This study identifies TAK1 as a therapeutic target in pancreatic cancer that enhances anti-tumor immunity and sensitizes tumors to checkpoint blockade.

bioRxiv · Oct 8, 2025 · PreprintCancer Biology